Förbundet Blödarsjuka
AROSENIUS LECTURES AND AWARDS
1997
Dr Mark Kay,
University of Washington, Seattle, USA
Held in Stockholm
1998
Dr Inder Verma
The Salk Institute, La Jolla, USA
Held at the WFH congress in The Hague
1999
Professor Christine A Lee
The Royal Free Hospital, London, UK
Held in Stockholm
2000
Dr Katerine A. High,
Children´s Hospital of Philadelphia, USA
Held at Gene Therapy Congress in Stockholm
2001
Dr Paul Giangrande,
Oxford Hemophilia Centre, UK
Held at the EHC congress in Malmö
2002
Professor Stefan Karlsson, Department of Molecular Medicine and Gene Therapy Lund, Sweden
”Development of Gene Therapy for Blood Disorders by Gene Transfer into Hematopoietic Stem Cells”.
Held at the WFH Congress in Seville
2003
Professor Mammen Chandy
Christian Medical College Hospital, Vellore, India
“Ethical Dilemmas in Hemophilia Treatment in Development Countries“
Held at the Arosenius symposium in Helsinki
2004
Professor Ian Peake
University of Sheffield, UK
”Genotype/Phenotype Correlation in von Willebrand Desease and its Impact on von Willebrand Nomenclature”
Held at the WFH congress in Bangkok
2005
Professor Victor Blanchette
Hospital for Sick Children, Toronto, Canada
“Towards Optimization of Factor Prophylaxis in Hemophilia”
Held at the Arosenius symposium in St Petersburg
2006
Professor David Lillicrap
Queens University, Kingston, Canada
”Hemophilia Gene Transfer: Past Lessons and Current Obstacles”
Held at the WFH congress in Vancouver
2007
Professor Wolfgang Schramm
Ludwig-Maximilians-Universität, München, Germany
“Hemophilia in Europe with Respect to Clinical Outcome, Quality of Life and Care Resources”
Held at the Arosenius symposium in Stockholm
2008
Professor Donna M. DiMichele
Cornell Medical College, New York, USA
“Aspects on Surgial Procedures in Early Infancy”
Held at the WFH congress in Istanbul
2009
Professor Johannes Oldenburg
University Clinic, Bonn, Germany
“Anti-factor VIII antibodies – who, why and can it be prevented?”
Held at the Arosenius symposium in Malmö
2010
Professor Pier Manucci
A. Bianchi Bonomi Hemophilia Center, Milano, Italien
“Treatment of Von Willebrand Disease”
Held at the EAHAD congress in Edinburgh
MD Katherine A. High, University of Pennsylvania School of Medicine and Howard Hughes Medical Institute, Philadelphia, USA
”Gene Therapy and Inhibitor Development; The Final Solution?”
Held at the WFH congress in Buenos Aires
2011
Professor. E. C. Rodriguez-Merchan Department of Orthopaedic Surgery, La Paz University Hospital, Madrid, Spain
“Haemophilic arthropathy - Aspects of Current Management: Orthopaedic Surgery in Haemophilia”
Held at the EAHAD congress in Geneva
2012
Professor Edward G. D. Tuddenham,
University College London, UK
“Gene theraphy trial in severe hemophilia B”
Held at the EAHAD congress in Rome and published in Hemophilia Volume 18, issue 1, January 2012
Professor Erik Berntorp, Department for Coagulation Disorders, Malmö University Hospital, Malmö, Sweden
“History of Prophylaxis”
Held at the WFH congress in Paris
2013
Professor Sven Björkman, Uppsala University, Uppsala, Sweden
"Pharmacokinetics of plasma-derived and recombinant factor IX"
Held at the EAHAD congress in Warsaw and published in Hemophilia Volume 19, issue 1, November 2013
2014
Professor Johannes Oldenburg
University Clinic, Bonn, Germany
“Anti-factor VIII antibodies – who, why and can it be prevented?”
Held at the EAHAD meeting in february in Brussels
Professor Alok Srivastava, Department of Haematology, Christian Medical College, Vellore, India
“Defining care in haemophilia: beyond the treatment guidelines”
Held at the WFH congress in Melbourne
2015
Professor Riitta Lassila, Hospital District of Helsinki and Uusimaa, Helsinki, Finland
”Platelet procoagulant activity”
Held at the EAHAD meeting in february in Helsinki
2016
Professor Erik Berntorp, Department for Coagulation Disorders, Malmö University Hospital, Malmö, Sweden
“The use of prophylaxis in vWD – remaining issues”
Held at the EAHAD congress in Malmö
Professor Midori Shima, Department of Pediatrics, Nara Medical University, Japan
“Factor VIII–Mimetic Function of Humanized Bispecific Antibody in Hemophilia A”
Held at the WFH congress in Orlando
2017
Jenny Goudemand
Importance of phenotypic and genotypic characterization for treatment of Von Willebrand Disease: lessons from the French cohor
Held at EAHAD 2017 Paris, France
2018
Evelien Mause-Bunschoten
Ageing and haemophilia
Held att EAHAD 2018, Madrid, spain
Amy Shapiro
Optimizing bleed prevention: womb to tomb.
Held at WFH 2019, Glasgow, Irland
2019
Prof. Philippe De Moerloose,
Haemophilia in Africa
Held att EAHAD 2019, Prague
2020
Brian O´Mahony
Hemophilia Care in Europe
Held in EAHAD Amsterdam
Steven Pipe, MD
Gene therapy
Held at WFH 2020, Virtual Congress
2021
Marilyn Manco-Johnson
Prophylaxis in haemophilia
Held at EAHAD, Virtual Congress
